author-photo

Priscillia Koe

3

Papers

10

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Phase I study of the safety and tolerability of the Exportin 1 (XPO1) inhibitor Selinexor (SXR) in Asian patients (pts) with advanced solid cancers.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)